ロード中...
Cholinesterase inhibitors may not benefit mild cognitive impairment and mild Alzheimer disease dementia
INTRODUCTION: We investigated whether cholinesterase inhibitors (ChEIs) benefit cognitive outcomes in mild cognitive impairment (MCI) due to Alzheimer disease (AD) and in mild AD dementia. METHODS: Data from 2,242 individuals, clinically diagnosed with MCI due to AD (MCI-AD, Clinical Dementia Rating...
保存先:
| 出版年: | Alzheimer Dis Assoc Disord |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6542289/ https://ncbi.nlm.nih.gov/pubmed/30633043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WAD.0000000000000291 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|